“…Several models have been proposed to explain how HIV-1 Vif overcomes the antiviral function of A3G, but the dominant one according to current knowledge illustrates that HIV-1 Vif interacts with A3G to induce its proteasomal degradation (16,43,48,52,62,65,76). During this process, HIV-1 Vif mediates the formation of the Cullin 5-Vif-A3G ubiquitin E3 ligase complex, which marks A3G for proteasomal degradation (34,45,51,64,76,77). The H-X(5)-C-X(17-18)-C-X(3-5)-H (45,53,72,73) and LPX4L (64) motifs in the C-terminal region of Vif bind to Cullin 5, while another C-terminal SLQ(Y/F)LA domain interacts with Elongin B and Elongin C (51,76,77), which help to recruit Vif into the Cullin 5-ubiquitin E3 ligase complex.…”